Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia

ClinicalTrials.gov ID: NCT05156047

Public ClinicalTrials.gov record NCT05156047. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 12:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to evaluate the safety and efficacy of pitolisant compared with placebo in treating excessive daytime sleepiness (EDS) in participants with idiopathic hypersomnia (IH) age ≥18 years. Key secondary objectives of this study are to assess the impact of pitolisant on: * Overall symptoms of IH * Participant impression of overall change in their symptoms of IH * Investigator assessment of overall disease severity of IH Other secondary objectives of this study are to assess the impact of pitolisant in participants with IH on: * Participant impression of overall severity of their EDS * Functional status and activities of daily living * Sleep-related impairment * Sleep inertia * Cognitive function

Study identification

NCT ID
NCT05156047
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
214 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 25, 2022 (Actual)
Primary completion
Sep 8, 2023 (Actual)
Completion
Sep 8, 2023 (Actual)
Last update posted
Sep 25, 2026

2022 – 2023

United States locations

U.S. sites
58
U.S. states
25
U.S. cities
56
Facility City State ZIP Site status
Phoenix Medical Group Peoria Arizona 85381 —
Mayo Clinic Scottsdale Arizona 85259 —
Cedars-Sinai Medical Towers Los Angeles California 90048 —
University of California- Los Angeles Los Angeles California 90095 —
Sleep Medicine Specialists of California San Ramon California 94583 —
SDS Clinical Trials Inc. Santa Ana California 92705 —
Santa Monica Clinical Trials Santa Monica California 90404 —
Alpine Clinical Research Center Boulder Colorado 80301 —
Norwalk Hospital Sleep Center Norwalk Connecticut 06850 —
Meris Clinical Research Brandon Florida 33511 —
St. Francis Medical Institute Clearwater Florida 33765 —
Sleep Medicine Specialists of South Florida, PA Miami Florida 33126 —
Pasadena Center For Medical Research, LLC St. Petersburg Florida 33763 —
Florida Pediatric Research Institute Winter Park Florida 32789 —
Neurotrials Research Inc. Atlanta Georgia 30328 —
The Neurological Center of North GA Gainesville Georgia 30501 —
Northwestern University Chicago Illinois 60611 —
NorthShore Uni HealthSys-Glenbrook Hospital Glenview Illinois 60026 —
OSF HealthCare Saint Francis Medical Center Peoria Illinois 61637 —
Helene A. Emsellem MD PC Chevy Chase Maryland 20815 —
Boston Children's Hospital Boston Massachusetts 02115 —
Neurocare, INC Newton Massachusetts 02459 —
Henry Ford Health System Novi Michigan 48377 —
Bronson Sleep Health Portage Michigan 49024 —
Clinical Neurophysiology Services Sterling Heights Michigan 48314 —
Minnesota Lung Center Edina Minnesota 55125 —
Minnesota Lung Center Woodbury Minnesota 55125 —
St. Luke's Sleep Medicine and Research Center Chesterfield Missouri 63017 —
Clayton Sleep Institute St Louis Missouri 63123 —
Great Plains Health North Platte Nebraska 69101 —
Neurology Specialists of Monmouth County, PA West Long Branch New Jersey 07764 —
Northwell Health New Hyde Park New York 11042 —
Research Carolina Elite LLC Denver North Carolina 28037 —
Duke University School of Medicine Durham North Carolina 27705 —
Clinical Research of Gastonia Gastonia North Carolina 28054 —
ARSM Research Huntersville North Carolina 28078 —
NeuroScience Research Center, LLC Canton Ohio 44718 —
Intrepid Research, LLC Cincinnati Ohio 45245 —
Rainbow Babies Children's Hospital Cleveland Ohio 44106 —
Cleveland Clinic Cleveland Ohio 44195 —
Ohio Sleep Medicine and Neuroscience Institute Dublin Ohio 43017 —
North Star Medical Research Middleburg Ohio 44130 —
CardioVoyage Ardmore Oklahoma 73401 —
Brian Abaluck, LLC Paoli Pennsylvania 19301 —
Abington Neurological Associates Willow Grove Pennsylvania 19090 —
Respiratory Specialists Wyomissing Pennsylvania 19610 —
Medical University of South Carolina- Institute of Psychiatry Charleston South Carolina 29425 —
Bogan Sleep Consultants Columbia South Carolina 29201 —
Lowcountry Lung Critical Care North Charleston South Carolina 29406 —
Advanced Center for Sleep Disorders Chattanooga Tennessee 37421 —
Neurology Clinic, P.C. Cordova Tennessee 38018 —
FutureSearch Trials of Neurology LP Austin Texas 78731 —
Central Texas Neurology Consultants, PA Round Rock Texas 78681 —
Comprehensive Sleep Medicine Associates Sugar Land Texas 77478 —
Northwest Houston Neurology and Sleep Tomball Texas 77375 —
Children's Hospital of the King's Daughter Norfolk Virginia 23507 —
West Virginia University - Department of Neurology Morgantown West Virginia 26506 —
University of Wisconsin-Madison Madison Wisconsin 53719 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05156047, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 25, 2026 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05156047 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →